Substance.com

Get involved in the conversation.

Douglas Capraro Douglas Capraro

Hangover-Free Alcohol Has Finally Arrived, Kind Of


A new synthetic alcohol could make you drunk without the negative side effects. But will it ever make it past the red tape?

3 Substance
Score


Professor David Nutt believes that his synthetic hangover-free alcohol has "long-term health benefits to society". Photo Via

Professor David Nutt believes that his synthetic hangover-free alcohol has “long-term health benefits to society”. Photo Via

Can you imagine hitting the bottle as hard as you want with no physical consequences the next morning? It could become possible. A new synthetic alcohol substitute called alcosynth would eliminate hangovers from the equation, also supposedly doing away with the chemically addictive side effects of alcohol. But is hangover-free alcohol too good to be true?

Alcosynth was created by Professor David Nutt, the former chief drug advisor to the UK government and the man behind a radical new study on psychedelic drugs. His new compound, classified as a benzodiazepine, would act as a non-toxic inebriant with similar effects to alcohol. Its benefits include removing the risks of hangovers, liver toxicity, aggression and loss of control. So what’s the catch? The costs for human trials and legal fees would surpass $1.5 million. Regardless, Nutt is optimistic. He says the beverage industry in particular should take his synthetic alcohol seriously, especially from a standpoint of corporate social responsibility. “The drinks industry should see this as a natural stage in the evolution of their products which will ultimately help them avoid expensive litigation costs,” says Nutt.

In addition to alcosynth, Nutt has  concocted a second compound—a capsule called “chaperone” that would regulate the effects of regular alcohol intake. “Take a pill with booze, and it’s impossible to become drunk to the point of incapacitation,” he says. The price point for this “sober up pill” would be steep, and it could potentially be misused. But Nutt argues it would help reduce alcohol-related crime and drunk driving accidents.

Despite pushback from strict drug laws in both Australia and his native UK, Nutt shows no signs of slowing down production on his new products. The Telegraph reports that he has applied for patents on 85 new chemical compounds in the alcosynth and chaperone families. Meanwhile, drinkers can keep nursing hangovers with advil and fried eggs, and remain optimistic, like Nutt, for a hangover-free future.